Folger Hill Asset Management’s Pacira BioSciences PCRX Stock Holding History

Folger Hill Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-48,639	Closed	-$1.62M	–	336
2016 Q3	$1.66M	Sell	48,639 -261,005	-84%	-$10.2M	0.1%	194
2016 Q2	$10.4M	Buy	309,644 +118,010	+62%	+$5.8M	0.81%	42
2016 Q1	$10.2M	Sell	191,634 -67,011	-26%	-$3.92M	0.57%	42
2015 Q4	$19.9M	Buy	+258,645	New	+$14.6M	1.2%	23

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Folger Hill Asset Management's PCRX Position: Q4 2016 in Review

Folger Hill Asset Management sold out of Pacira BioSciences (PCRX) in Q4 2016, closing a stake of 48,639 shares — an estimated $1.62M sold.

Folger Hill Asset Management first reported a position in PCRX in Q4 2015 and held it in 4 quarters. The position peaked at $19.9M in Q4 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

Folger Hill Asset Management reported no remaining Pacira BioSciences position as of Q4 2016 after selling out during the quarter.
Folger Hill Asset Management sold 48,639 Pacira BioSciences shares in Q4 2016, an estimated $1.62M.
Folger Hill Asset Management first reported a position in Pacira BioSciences in Q4 2015 and held it in 4 quarters.
Folger Hill Asset Management's Pacira BioSciences position peaked at $19.9M in Q4 2015.
182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on Folger Hill Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.